FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> pharmaceutical social media

Pharma near top in litigation risk thanks to social media, Web 2.0

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

Drug companies tied with travel companies in the risk of litigation due to social networking sites and other Web 2.0 services. Pharma trailed energy, which earned the gold medal, by just 0.25 on a scale of 10, but somehow came out more at risk than the oft-vilified finance companies. The poll rated the 100 companies that comprise the Financial Times Stock Exchange, two-thirds of which have previously been sued or initiated legal action. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about pharmaceutical social media